What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Invicta Diagnostic Limited IPO?

Invicta Diagnostic Limited IPO has received a total subscription of 4.34 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Invicta Diagnostic Limited

ListedSME

Healthcare · NSE

Incorporated in January 2021, Invicta Diagnostic Limited (operating as PC Diagnostics) is a Mumbai-based diagnostic services provider offering integrated radiology and pathology solutions through a hub-and-spoke model spread across the Mumbai Metropolitan Region, comprising a flagship advanced diagnostic hub in Thane West, three additional hubs in Bhayandar, Byculla, and Marol, and four spokes focused on basic imaging and sample collection; the company provides around 60 routine and 487 specialised pathology tests along with 96 basic and 130 advanced radiology tests, supported by a strong home-collection network and a team of 5 laboratory doctors, 20 radiologists, 127 technical staff, and 105 permanent employees as of May 31, 2025.

Price Band

₹80 – ₹85

Issue Size

₹28.12 Cr

Lot Size

1600 shares

GMP

—

Est. Listing

₹85

at current GMP

Subscribed

4.34x

overall

Open

1 Dec 2025

3 Dec 2025

Allotment

4 Dec 2025

Refund

5 Dec 2025

Demat Credit

6 Dec 2025

Listing

8 Dec 2025

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

4.34x

Total Demand

QIB Multiplier

3.51x

Institutions & Funds

NII / HNI

7.27x

High Net-Worth

Retail (RII)

3.44x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 4.34x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	534,400	1,875,200	3.51x
NIB	542,400	3,940,800	7.27x
HNIs(10L +)	361,600	2,806,400	7.76x
HNIs (2-10L)	180,800	1,134,400	6.27x
RETAIL	1,267,200	4,361,600	3.44x
Total	2,886,400	14,118,400	4.34x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 4.28x

Category	Applications Reserved	Applications Received	Times Subscribed
QIB	—	3	0.00x
NIB	—	407	0.00x
RETAIL	396	1,363	3.44x
HNIs(10L +)	75	189	2.52x
HNIs (2-10L)	38	218	5.74x
Total Applications	509	2,180	4.28x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Invicta Diagnostic Limited Public Issue & Market Profile

Invicta Diagnostic Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹28.12 Crores. The shares are offered at a price band of ₹80 to ₹85 per equity share on NSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.

Bidding & Quota Instructions:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1600 shares (approx. ₹1,36,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Allotment Reconciliation Schedule:

Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-12-06, while un-allotted funds or UPI block mandates will be released on 2025-12-05.

Frequently Asked Questions

What is Invicta Diagnostic Limited IPO GMP today?

Currently, Invicta Diagnostic Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹80 to ₹85 per equity share.

What is the expected profit per lot for Invicta Diagnostic Limited IPO?

The retail lot size is 1600 shares requiring a minimum application amount of ₹1,36,000. Expected listing price is ₹85 per equity share.

What is the issue size and price band for Invicta Diagnostic Limited IPO?

The Invicta Diagnostic Limited IPO aggregate issue size is ₹28.12 Crores with an equity price band set at ₹80 to ₹85 per equity share. The retail lot size is 1600 shares requiring a minimum capital outlay of approx. ₹1,36,000.

How can I check Invicta Diagnostic Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 4.34x (Retail: 3.44x, QIB: 3.51x, NII: 7.27x). You can track live multiples directly on our dedicated subscription page.

Where and when will Invicta Diagnostic Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2025-12-04. Investors can verify status using PAN card or application number.

When is the listing date for Invicta Diagnostic Limited IPO?

Invicta Diagnostic Limited shares are scheduled to list on NSE on 2025-12-08.